HDx Therapy
Expanded Hemodialysis may make a World of Difference for patients, clinicians & healthcare systems
One Change can Transform HD Treatment
HDx therapy enabled by Theranova dialyzer* brings us one step closer to the natural kidney.1 It helps with efficient removal of large-middle molecules (LMMs)2 which have been linked to inflammation, cardiovascular disease, and other co-morbidities in dialysis patients.3,4
HDx therapy has the potential to improve clinical outcomes associated with reduction of cardiovascular event rate and mortality rate when compared to HF-HD.5,6,7,8,9
Consensus of Experts
Expanded Hemodialysis describes a treatment using a filter with a high molecular weight retention onset and a molecular weight cut-off similar to or exceeding high-flux HD.10,11
Due to changes in filter geometry with a smaller inner diameter to promote internal filtration and back filtration, the volume of convective transport exceeds that of high-flux HD. This is combined with diffusive transport, without the use of replacement fluids.10,11
This allows augmented clearances of molecules in a very broad spectrum of molecular weight from small water-soluble molecules to middle molecules with a molecular weight/size cutoff just below albumin.10,11
Standardisation of Nomenclature
Learn moreDefinition of Extracorporeal Techniques
Learn moreClassification of Uremic Toxins and Their Role in Kidney Failure
Learn moreWatch patient testimonial
Watch Robert Wahby share his story about undergoing HDx therapy and understand the science behind it with the renowned Dr. McIntyre.